Truncated activin type I receptor Alk4 isoforms are dominant negative receptors inhibiting activin signaling
about
sameAs
Cripto-1 activates nodal- and ALK4-dependent and -independent signaling pathways in mammary epithelial CellsActivin controls skin morphogenesis and wound repair predominantly via stromal cells and in a concentration-dependent manner via keratinocytesPituitary adenomas: historical perspective, surgical management and future directionsXenopus Dab2 is required for embryonic angiogenesisActivin A inhibits activation of human primordial follicles in vitro.Role of myoepithelial cells in breast tumor progression.Cellular and molecular specificity of pituitary gland physiology.Regulation of growth hormone expression by Delta-like protein 1 (Dlk1).Cell-type specific modulation of pituitary cells by activin, inhibin and follistatin.Tumor suppression by MEG3 lncRNA in a human pituitary tumor derived cell line.Mechanisms of disease: The pathogenesis of pituitary tumors.Activin receptor antagonists for cancer-related anemia and bone disease.Loss of ACVRIB leads to increased squamous cell carcinoma aggressiveness through alterations in cell-cell and cell-matrix adhesion proteins.Dihydrofolate Reductase/Thymidylate Synthase Fine-Tunes the Folate Status and Controls Redox Homeostasis in Plants.Activin A/AB/B binds Activin Receptor ACVR2A/B:ACVR1BACVR2A/B (ActRIIA/B) phosphorylates ACVR1B (ActRIB; ALK4) in response to Activin
P2860
Q24292510-C6CD3AEF-0271-4C97-ACB8-CA7744DB8B21Q24671636-2A2D4673-433C-4CCB-8FB9-C5ED8416A2BBQ26779749-409A0BD9-3454-49E5-B191-DAC2CCA45141Q33266946-3399C43D-6EFF-4F7F-89CA-2AE0F1ACE2C2Q33790879-ABF10E55-4BEE-4587-8456-1EC76FC86EEEQ33995825-3B3DB268-6211-4D97-8D6B-221F80C8DB55Q34251305-6E1189E2-75DF-44CE-92B9-969B9C6DA453Q35987534-E98C5D43-BFDE-45D9-A4CF-92173F01CB12Q36007410-34C0A4B9-A64F-4DEC-8D6E-F93E94D3F133Q36161900-870C4774-35A1-44E8-AE77-83E665ED42E2Q36576996-1009B134-D195-4DA4-89D3-011373F6D365Q38057813-701A5EAA-970C-4083-8C8E-FFA7B541C470Q47193421-B0E70B96-676D-4120-9DA3-EDEA8A340906Q47758921-8D5337C6-D135-4414-82CD-9068E9F4BA3AQ50298218-73290944-407C-4E2C-9217-23673F8CDAF3Q50298220-3E41B738-2532-4F6E-8B02-3DEDA002AF49
P2860
Truncated activin type I receptor Alk4 isoforms are dominant negative receptors inhibiting activin signaling
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Truncated activin type I recep ...... s inhibiting activin signaling
@ast
Truncated activin type I recep ...... s inhibiting activin signaling
@en
Truncated activin type I recep ...... s inhibiting activin signaling
@en-gb
Truncated activin type I recep ...... s inhibiting activin signaling
@nl
type
label
Truncated activin type I recep ...... s inhibiting activin signaling
@ast
Truncated activin type I recep ...... s inhibiting activin signaling
@en
Truncated activin type I recep ...... s inhibiting activin signaling
@en-gb
Truncated activin type I recep ...... s inhibiting activin signaling
@nl
altLabel
Truncated Activin Type I Recep ...... s Inhibiting Activin Signaling
@ast
Truncated Activin Type I Recep ...... s Inhibiting Activin Signaling
@en
prefLabel
Truncated activin type I recep ...... s inhibiting activin signaling
@ast
Truncated activin type I recep ...... s inhibiting activin signaling
@en
Truncated activin type I recep ...... s inhibiting activin signaling
@en-gb
Truncated activin type I recep ...... s inhibiting activin signaling
@nl
P2093
P356
P1476
Truncated Activin Type I Recep ...... s Inhibiting Activin Signaling
@en
Truncated activin type I recep ...... s inhibiting activin signaling
@en
P2093
A Klibanski
D C Danila
Daniel C. Danila
Daniel P. Sigai
Huiping Sun
S R Johnson
Stacey R. Johnson
P304
P356
10.1210/MEND.14.12.0570
P407
P577
2000-12-01T00:00:00Z